Regulatory Authorities Worldwide are Scrutinizing GDPs During Inspections
This article was originally published in PharmAsia News
Executive Summary
Regulators worldwide are increasingly scrutinizing pharmaceutical manufacturers’ good distribution practices during GMP inspections as GDP regulations continue to proliferate, says an industry representative who discusses how to comply with different regulations.